Shandong Jincheng Pharmaceutical Group Co.,Ltd.’s Net Profit Dropped 50.6% in First Half of 2023

Shandong Jincheng Pharmaceutical Group Co.,Ltd. (山东金城医药集团股份有限公司) (300233.SZ) reported a net profit of 110.8 million yuan in the first half of 2023, down 50.6% year-on-year.

Meanwhile, the company posted 1.7 billion yuan in revenue, down 7.9% year-on-year.

At the end of the reporting period, it had 5.8 billion yuan in total assets and 2.1 billion yuan in total liabilities, with a liability-to-asset ratio of 36.1%.